Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescein Use During Cystoscopy
NCT02703558Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Mar 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of fluorescein in pelvic organ prolapse (POP) and stress urinary incontinence (SUI) (3 arms), sponsored by Johns Hopkins University. Primary endpoints: Time required to complete cystoscopy and Time required to visualize ureteral jets. Planned start Mar 2016; status: withdrawn.
02
Drugs
fluorescein
03
Conditions
pelvic organ prolapse (POP)stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT02703558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02703558.